Nevertheless, it is tempting to speculate that sex-linked traits could affect susceptibility to clinical penetrance and spectrum of SETD1B variants, as female-protective effects have been proposed for other neurodevelopmental disorders [31, 32]. This evidence concerns the gene SETD1B and neurodevelopmental disorder.